{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:02:06Z","timestamp":1787504526588,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clinthera.2020.11.009","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:49:00Z","timestamp":1606956540000},"page":"e19-e31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review"],"prefix":"10.1016","volume":"43","author":[{"given":"Diana-Lynn S.","family":"Que","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Dominic G.","family":"Jamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.11.009_bib1","first-page":"1","article-title":"CDP-choline: pharmacological and clinical review","volume":"17","author":"Secades","year":"1995","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2020.11.009_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/ciia.2006.1.3.247","article-title":"Citicoline (Cognizin) in the treatment of cognitive impairment","volume":"1","author":"Fioravanti","year":"2006","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clinthera.2020.11.009_bib3","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1161\/STROKEAHA.110.597435","article-title":"Neuroprotection and recovery: recent data at the bench on citicoline","volume":"42","author":"Hurtado","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2020.11.009_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2020.11.009_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fneur.2019.00148","article-title":"Dietary Vitamin E as a protective factor for Parkinson's disease: clinical and experimental evidence","volume":"10","author":"Schirinzi","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.clinthera.2020.11.009_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(89)90364-8","article-title":"Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membrane of rat corpus striatum","volume":"484","author":"Ulus","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.clinthera.2020.11.009_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/eat.20658","article-title":"Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods","volume":"43","author":"Killgore","year":"2010","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.clinthera.2020.11.009_bib8","first-page":"239","article-title":"Citicoline in the treatment of Parkinson's disease","volume":"13","author":"Marti Masso","year":"1991","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2020.11.009_bib9","first-page":"489","article-title":"Citicoline in the treatment of Parkinson's disease","volume":"12","author":"Eberhardt","year":"1990","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2020.11.009_bib10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1586\/14737175.2015.1088783","article-title":"Asian perspectives on the recognition and management of levodopa \u2018wearing-off\u2019 in Parkinson's disease","volume":"15","author":"Bhidayasiri","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.clinthera.2020.11.009_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/nmt-2017-0014","article-title":"Treatment gaps in Parkinson's disease care in the Philippines","volume":"7","author":"Jamora","year":"2017","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.clinthera.2020.11.009_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"Plos Med"},{"key":"10.1016\/j.clinthera.2020.11.009_bib13","first-page":"664","article-title":"Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease","volume":"10","author":"Cubells","year":"1988","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2020.11.009_bib14","first-page":"428","article-title":"Quantitative testmethoden zur objeckivierung des effektes einer L-dopa langseitherapia beim Parkinson syndrome","volume":"44","author":"Gerstenbrand","year":"1973","journal-title":"Nevenarzt"},{"key":"10.1016\/j.clinthera.2020.11.009_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000117914","article-title":"New strategies in the management of Parkinson's disease: a biological approach using a phospholipid precursor (CDP-Choline)","volume":"8","author":"Agnoli","year":"1982","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.clinthera.2020.11.009_bib16","first-page":"112","article-title":"Clinical evaluation of CDP-choline in patients with Parkinson's disease","volume":"76","author":"Rainer","year":"1977","journal-title":"IPHAR-Report"},{"key":"10.1016\/j.clinthera.2020.11.009_bib17","first-page":"4593","article-title":"Effect of citicoline adjuvant therapy on mild cognitive impairment in Parkinson's disease","volume":"9","author":"Li","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.clinthera.2020.11.009_bib18","series-title":"New Trends in Clinical Neuropharmacology: Calcium Antagonists, Acute Neurology, Headache and Movement Disorders","first-page":"289","article-title":"Multicenter trial: treatment of Parkinson's disease with CDP-choline (citicoline)","author":"Acosta","year":"1988"},{"key":"10.1016\/j.clinthera.2020.11.009_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jns.2010.08.027","article-title":"Citicoline use in cognitive decline: vascular and degenerative","volume":"299","author":"Garc\u00eda-Cobos","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.clinthera.2020.11.009_bib20","first-page":"52","article-title":"Effects of cytidine-5\u2019 diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain","volume":"239","author":"Martinet","year":"1979","journal-title":"Arch Int Pharmacodyn Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182030518X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182030518X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:54:37Z","timestamp":1758963277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182030518X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S014929182030518X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.11.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}